IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 213 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $714,228 | -95.7% | 74,167 | -95.3% | 0.00% | -100.0% |
| Q2 2023 | $16,636,535 | +31.4% | 1,563,584 | +29.9% | 0.01% | +28.6% |
| Q1 2023 | $12,665,670 | +265.2% | 1,203,961 | +330.1% | 0.01% | +250.0% |
| Q4 2022 | $3,468,098 | -63.5% | 279,911 | -69.5% | 0.00% | -66.7% |
| Q3 2022 | $9,501,000 | -76.1% | 917,082 | -73.4% | 0.01% | -72.7% |
| Q2 2022 | $39,695,000 | +369.3% | 3,442,750 | +412.0% | 0.02% | +450.0% |
| Q1 2022 | $8,459,000 | +77.6% | 672,441 | +64.6% | 0.00% | +100.0% |
| Q4 2021 | $4,764,000 | -10.5% | 408,582 | +0.3% | 0.00% | -33.3% |
| Q3 2021 | $5,322,000 | +314.8% | 407,494 | +308.4% | 0.00% | +200.0% |
| Q2 2021 | $1,283,000 | -84.6% | 99,766 | -86.6% | 0.00% | -75.0% |
| Q1 2021 | $8,354,000 | +415.7% | 747,212 | +425.2% | 0.00% | +300.0% |
| Q4 2020 | $1,620,000 | +13.7% | 142,269 | -10.2% | 0.00% | 0.0% |
| Q3 2020 | $1,425,000 | -72.5% | 158,365 | -68.5% | 0.00% | -75.0% |
| Q2 2020 | $5,186,000 | +181.5% | 502,503 | +175.1% | 0.00% | +100.0% |
| Q1 2020 | $1,842,000 | -88.4% | 182,673 | -84.7% | 0.00% | -80.0% |
| Q4 2019 | $15,939,000 | +225.1% | 1,197,597 | +109.6% | 0.01% | +233.3% |
| Q3 2019 | $4,903,000 | -27.3% | 571,290 | -7.3% | 0.00% | -25.0% |
| Q2 2019 | $6,743,000 | -37.4% | 616,502 | -22.6% | 0.00% | -33.3% |
| Q1 2019 | $10,769,000 | +1375.2% | 796,204 | +1025.9% | 0.01% | +500.0% |
| Q4 2018 | $730,000 | -95.0% | 70,714 | -91.0% | 0.00% | -75.0% |
| Q3 2018 | $14,459,000 | +24.7% | 783,380 | +29.1% | 0.00% | +33.3% |
| Q2 2018 | $11,598,000 | +43.1% | 606,642 | +15.5% | 0.00% | -25.0% |
| Q1 2018 | $8,105,000 | +65.3% | 525,427 | +60.5% | 0.00% | +33.3% |
| Q4 2017 | $4,903,000 | -82.0% | 327,281 | -81.0% | 0.00% | -84.2% |
| Q3 2017 | $27,192,000 | +90.5% | 1,724,374 | +128.1% | 0.02% | +90.0% |
| Q2 2017 | $14,273,000 | +173.5% | 756,123 | +147.1% | 0.01% | +150.0% |
| Q1 2017 | $5,219,000 | +62.3% | 306,027 | +45.4% | 0.00% | +33.3% |
| Q4 2016 | $3,216,000 | -47.9% | 210,418 | -45.8% | 0.00% | -25.0% |
| Q3 2016 | $6,168,000 | -55.0% | 388,530 | -62.9% | 0.00% | -60.0% |
| Q2 2016 | $13,708,000 | -22.9% | 1,048,613 | -35.4% | 0.01% | -23.1% |
| Q1 2016 | $17,769,000 | -8.1% | 1,624,351 | -2.7% | 0.01% | 0.0% |
| Q4 2015 | $19,340,000 | -43.2% | 1,668,824 | -48.9% | 0.01% | -50.0% |
| Q3 2015 | $34,029,000 | -62.7% | 3,266,118 | -56.8% | 0.03% | -55.2% |
| Q2 2015 | $91,231,000 | -14.5% | 7,565,022 | +13.5% | 0.06% | -12.1% |
| Q1 2015 | $106,652,000 | -0.8% | 6,665,883 | -5.0% | 0.07% | 0.0% |
| Q4 2014 | $107,517,000 | +54.8% | 7,018,198 | +30.9% | 0.07% | +53.5% |
| Q3 2014 | $69,449,000 | +16.0% | 5,361,005 | +37.3% | 0.04% | +4.9% |
| Q2 2014 | $59,855,000 | -23.6% | 3,904,596 | -38.6% | 0.04% | -26.8% |
| Q1 2014 | $78,382,000 | +39.9% | 6,362,424 | +31.8% | 0.06% | +40.0% |
| Q4 2013 | $56,046,000 | +35.0% | 4,827,608 | +37.7% | 0.04% | +29.0% |
| Q3 2013 | $41,515,000 | – | 3,506,529 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |